ABSTRACT
Since the publication of the previous edition of this volume, there has been substantial progress in a number of areas of multiple sclerosis (MS) research. Although immunosuppressive treatments continue to be developed and refined, more targeted immunomodulatory therapies are surfacing as we learn more about how the immune system works in health an
TABLE OF CONTENTS
part 1|2 pages
SECTION I: Introduction
part 2|2 pages
SECTION II: Clinical trial methodology
part 3|2 pages
SECTION III: Clinical trials of multiple sclerosis therapies
part 4|2 pages
SECTION IV: Therapy in clinical practice
